Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
European Cytokine Network|March 8, 2000
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remissionD Blaise, M Attal, J Reiffers, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Leukemia & Lymphoma|November 9, 2001
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study GroupE Jourdan, J Reiffers, A M Stoppa, et al.
Leukemia & Lymphoma|May 1, 1997
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remissionD Blaise, M Attal, J L Pico, et al.
Bone Marrow Transplantation|November 12, 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent yearsH W Auner, R Szydlo, J Hoek, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Annals of Hematology|June 10, 2023
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX studyM Macro, C Hulin, L Vincent, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Blood|October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML GroupE Wattel, A Guerci, B Hecquet, et al.
Pageof 12